Effects of inducible MEK1 activation on the cytokine dependency of lymphoid cells

W L Blalock1, M Pearce, F Chang

  • 1Department of Microbiology and Immunology, Brody School of Medicine at East Carolina University, Greenville, NC 27858, USA.

Leukemia
|May 23, 2001
PubMed

Insights

Activating the Raf/MEK/MAP kinase pathway with deltaMEK1:ER can make cytokine-dependent hematopoietic cells independent. This MAP kinase activation promotes cell proliferation and may involve autocrine signaling via GM-CSF.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Hematopoiesis

Background:

  • The Raf/MEK/MAP kinase cascade is crucial for transmitting growth signals from cell surface receptors.
  • Hematopoietic stem cell proliferation is often regulated by cytokines, and dysregulation can lead to disease.

Purpose of the Study:

  • To investigate the role of the MEK/MAP kinase pathway in overcoming cytokine dependency in hematopoietic cells.
  • To characterize the molecular mechanisms by which MEK activation influences cell proliferation and survival.

Main Methods:

  • Utilized a conditionally active MEK1 (deltaMEK1:ER) in the FL5.12 lymphoid hematopoietic cell line.
  • Assessed cytokine independence, MAP kinase activity, and gene expression (GM-CSF, GM-CSFRalpha, betac) upon deltaMEK1:ER activation.
  • Evaluated cell proliferation and viability using [3H]-thymidine incorporation and supernatant-conditioned media assays.

Main Results:

  • A low frequency of FL5.12 cells expressing deltaMEK1:ER became cytokine-independent.
  • Cytokine-independent cells exhibited higher MAP kinase activity and could be maintained with hormone stimulation.
  • Activated deltaMEK1:ER induced GM-CSF mRNA, suggesting autocrine proliferation, and decreased GM-CSF receptor expression.

Conclusions:

  • The MEK/MAP kinase pathway can confer cytokine independence to hematopoietic cells.
  • Activated MEK signaling may lead to autocrine GM-CSF production, driving proliferation.
  • These findings provide insights into MAP kinase regulation of hematopoietic cell proliferation and survival.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...